PLA2G16 Antikörper
Kurzübersicht für PLA2G16 Antikörper (ABIN597102)
Target
Alle PLA2G16 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Recognizes human PLA2G16.
-
Aufreinigung
- Immunoaffinity purified
-
Sterilität
- 0.2 μm filtered
-
Immunogen
- Purified, E. coli-derived recombinant human PLA2G16. (Asp12-Asp132, Accession #P53816).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ELISA (0.5 - 1 μg/mL), WB (1 μg/mL)
Usage: Suitable for use in ELISA and Western Blot. ELISA:0.5-1 μg/mL. Western Blot:1 μg/mL. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Sterile distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from a 0.2 um filtered solution in PBS, 5 % trehalose
-
Handhabung
- Aliquot to Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Lyophilized powder may be stored at -20°C. Stable for 1 year at -20°C. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Reconstituted product is stable for 1 year at -20°C.
-
-
- PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
-
Andere Bezeichnung
- PLA2G16 / HRASLS3
-
Hintergrund
-
Name/Gene ID: PLA2G16
Synonyms: PLA2G16, AdPLA, Adipose-specific PLA2, Group XVI phospholipase A1/A2, Group XVI phospholipase A2, H-REV107-1, HRAS-like suppressor 3, HRASLS3, HREV107-3, HRAS-like suppressor 1, HREV107-1, H-rev 107 protein homolog, HREV107, HRSL3, Phospholipase A2, group XVI -
Gen-ID
- 11145
-
UniProt
- P53816
-
Pathways
- Inositol Metabolic Process
Target
-